Peterlabs Holdings BhdXKLS:0171 +2.13%47 Quick Ratio is 1.34 as of Jun. 2025, which is 32% below its 10-year median of 1.97. GuruFocus rates XKLS:0171 with a GF Score™ of 47/100 and a GF Value™ of RM0.20 (Modestly Overvalued). The stock has 6 warning signs investors should review. Among 994 Drug Manufacturers companies, Peterlabs Holdings Bhd ranks worse than 53.22% on this metric.
Peterlabs Holdings Bhd has a quick ratio of 1.34. It generally indicates good short-term financial strength.
The historical rank and industry rank for Peterlabs Holdings Bhd's Quick Ratio or its related term are showing as below:
XKLS:0171'
s Quick Ratio Range Over the Past 10 Years
Min: 1.06 Med: 1.97 Max: 3.58
Current: 1.34
During the past 13 years, Peterlabs Holdings Bhd's highest Quick Ratio was 3.58. The lowest was 1.06. And the median was 1.97.
XKLS:0171's Quick Ratio is ranked worse than 53.22% of 994
companies
in the Drug Manufacturers industry
Industry Median: 1.45
vs XKLS:0171: 1.34
Peterlabs Holdings Bhd (XKLS:0171) Quick Ratio Explanation
The quick ratio is more conservative than the Current Ratio because it excludes inventories from current assets. The ratio derives its name presumably from the fact that assets such as cash and marketable securities are quick sources of cash. Inventories generally take time to be converted into cash, and if they have to be sold quickly, the company may have to accept a lower price than book value of these inventories. As a result, they are justifiably excluded from assets that are ready sources of immediate cash.
In general, low or decreasing quick ratios generally suggest that a company is over-leveraged, struggling to maintain or grow sales, paying bills too quickly or collecting receivables too slowly. On the other hand, a high or increasing quick ratio generally indicates that a company is experiencing solid top-line growth, quickly converting receivables into cash, and easily able to cover its financial obligations. Such companies often have faster inventory turnover and cash conversion cycles.
The higher the quick ratio, the better the company's liquidity position.
Peterlabs Holdings Bhd Quick Ratio Related Terms
Peterlabs Holdings Bhd Quick Ratio Historical Data
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
XKLS:0171 vs ZTS, UTHR, VTRS: Quick Ratio Comparison
For the Drug Manufacturers - Specialty & Generic subindustry, Peterlabs Holdings Bhd's Quick Ratio, along with its competitors' market caps and Quick Ratio data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Peterlabs Holdings Bhd Quick Ratio vs Drug Manufacturers Industry
For the Drug Manufacturers industry and Healthcare sector, Peterlabs Holdings Bhd's Quick Ratio distribution charts can be found below:
* The bar in red indicates where Peterlabs Holdings Bhd's Quick Ratio falls into.
The quick ratio measures a company's ability to meet its short-term obligations with its most liquid assets. For this reason, the ratio excludes inventories from current assets.
Peterlabs Holdings Bhd's Quick Ratio for the fiscal year that ended in Dec. 2023 is calculated as
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Peterlabs Holdings Bhd (XKLS:0171) has a Quick Ratio of 1.34 as of Jun. 2025. Quick ratio is the ratio of current assets less inventory to current liabilities. View historical data on Peterlabs Holdings Bhd and its competitors. This is 32% below median its historical median of 1.97. Over the past decade, Peterlabs Holdings Bhd's Quick Ratio has ranged from 1.06 to 3.58. According to the industry distribution chart, Peterlabs Holdings Bhd ranks #529 out of 994 companies in the Drug Manufacturers industry, placing it in the top 53.2%.
Is Peterlabs Holdings Bhd's Quick Ratio too high?
Peterlabs Holdings Bhd's current Quick Ratio of 1.34 is 32% below median its 10-year median of 1.97. Over the past 10 years, this metric has ranged from a low of 1.06 to a high of 3.58. The Drug Manufacturers industry median Quick Ratio is 1.45. Peterlabs Holdings Bhd's value of 1.34 is 7.6% below this industry median. Based on the distribution chart, Peterlabs Holdings Bhd ranks #529 out of 994 companies in the Drug Manufacturers industry, which is below the industry midpoint. Overall, Peterlabs Holdings Bhd has a GF Score™ of 47/100 and is considered Modestly Overvalued, reflecting its overall financial health beyond just this single metric.
How does Peterlabs Holdings Bhd's Quick Ratio compare to ZTS and UTHR?
According to the Drug Manufacturers industry distribution chart, Peterlabs Holdings Bhd ranks #529 out of 994 companies for Quick Ratio. This places Peterlabs Holdings Bhd in the lower half of its industry. The industry median Quick Ratio is 1.45. Peterlabs Holdings Bhd's value of 1.34 is 7.6% below this benchmark. Historically, Peterlabs Holdings Bhd's own Quick Ratio has ranged from 1.06 to 3.58 over the past decade. While the company's 10-year median is 1.97 vs. the industry median of 1.45, Peterlabs Holdings Bhd has consistently been below the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Quick Ratio for a Drug Manufacturers company?
The median Quick Ratio among Drug Manufacturers companies is 1.45, based on 994 companies in the industry. Companies in the top quartile (top 25%) have a Quick Ratio significantly above this median, while those in the bottom quartile fall well below. However, Quick Ratio should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Peterlabs Holdings Bhd's current Quick Ratio of 1.34 is 7.6% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Quick Ratio mean?
A high Quick Ratio can signal that a stock is expensive relative to its fundamentals. Quick ratio is the ratio of current assets less inventory to current liabilities. View historical data on Peterlabs Holdings Bhd and its competitors. For the Drug Manufacturers industry, the median Quick Ratio is 1.45 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Peterlabs Holdings Bhd's current Quick Ratio is 1.34, which is 32% below median its own 10-year median of 1.97. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Peterlabs Holdings Bhd stock overvalued right now?
Based on GuruFocus' analysis, Peterlabs Holdings Bhd (XKLS:0171) is currently considered Modestly Overvalued. The stock's GF Value™ is RM0.20, compared to a current price of RM0.24 — trading 20% above its estimated fair value. The current Quick Ratio is 1.34, which is 32% below median its 10-year median of 1.97 and 7.6% below the Drug Manufacturers industry median of 1.45. Peterlabs Holdings Bhd's overall GF Score™ is 47/100 with 6 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Quick Ratio calculated?
Quick Ratio is calculated from a company's financial statements. For Peterlabs Holdings Bhd (XKLS:0171), the current Quick Ratio is 1.34 as of Jun. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Peterlabs Holdings Bhd (XKLS:0171) Overvalued in 2026?
Based on GuruFocus' analysis, Peterlabs Holdings Bhd stock appears to be overvalued.
The current stock price of RM0.24 is trading 20% above its estimated GF Value™ of RM0.20.
GuruFocus considers Peterlabs Holdings Bhd to be Modestly Overvalued.
Key valuation signals for XKLS:0171:
Quick Ratio: 1.34 (32% below median its 10-year median of 1.97)
GF Value™: RM0.20 vs. price of RM0.24 (20% above fair value)
Industry Position: 7.6% below the Drug Manufacturers median (#529 of 994)
No single metric tells the full story. See the XKLS:0171 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Peterlabs Holdings Bhd is engaged in the manufacturing, distribution, export, and trading of animal health and nutrition products. The Group offers biosecurity and disinfectants, compound feed supplements, feed additives, nutritional premixes, pharmaceuticals, and water-soluble supplements, as well as farm management, technical advisory services, raw material analysis, and feed formulation. Its segments are Manufacturing, which covers the manufacturing and distribution of animal health and nutrition products; Trading, which involves the trading and distribution of animal health and nutrition products and consumer goods, and contributes the majority of its revenue; and Others, which provides investment holding services. The company operates in Malaysia and internationally.
47GF Score
Get the complete analysis for XKLS:0171
Quick Ratio is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
XKLS:0171 has been successfully added to your 
